Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...
Most organizations have some type of multifunctional committee set up to evaluate generative AI applications. Those ...
Most organizations have some type of multi-functional committee set up to evaluate generative AI applications. Those ...
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results